image: "Although an in vivo role for microcins has been suggested for 40 years, it has never been convincingly demonstrated," says Manuela Raffatellu, UCI associate professor of microbiology & molecular genetics. "We show that in an inflamed intestine, microcins help a probiotic strain limit the growth of some harmful bacteria." view more
Credit: Steve Zylius / UCI
Irvine, Calif., Nov. 3, 2016 -- Few treatments exist for bacteria-caused intestinal inflammation that leads to diarrhea, fever and abdominal cramps. But University of California, Irvine microbiologists have demonstrated a new approach that may lead to more effective remedies.
In the journal Nature, Manuela Raffatellu, associate professor of microbiology & molecular genetics, and colleagues provide the first evidence that small protein molecules called microcins, produced by beneficial gut microbes, play a critical part in blocking certain illness-causing bacteria in inflamed intestines.
In their study, the researchers show that a probiotic strain of E. coli called Nissle 1917 utilizes microcins to inhibit the pathogen salmonella and an invasive form of E. coli (isolated from patients with inflammatory bowel disease).
"Although an in vivo role for microcins has been suggested for 40 years, it has never been convincingly demonstrated," said Raffatellu, who's affiliated with UCI's Institute for Immunology. "We hypothesize that their role was missed because, as our data indicate, microcins do not seem effective in noninflamed intestines. In contrast, we show that in an inflamed intestine, microcins help a probiotic strain limit the growth of some harmful bacteria."
She added that microcins are essential for the therapeutic activity of E. coli Nissle, and her next step is to purify microcins and test whether they can be given as targeted antibiotics.
###
Martina Sassone-Corsi, Sean-Paul Nuccio, Henry Liu, Dulcemaria Hernandez, Christine Vu, Amy Takahashi and Robert Edwards of UCI contributed to the study, which is abstracted at http://www.nature.com/nature/journal/vaap/ncurrent/full/nature20557.html (subscription needed for complete paper). It was supported by National Institutes of Health grants AI083663, AI101784, AI114625 and AI105374, as well as the Burroughs Wellcome Fund.
About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 30,000 students and offers 192 degree programs. It's located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer, contributing $5 billion annually to the local economy. For more on UCI, visit http://www.uci.edu.
Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.
Journal
Nature